These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 16613092

  • 21. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.
    Konturek JW, Bielański W, Konturek SJ, Domschke W.
    J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296
    [Abstract] [Full Text] [Related]

  • 22. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T, Konturek PC, Kwiecien S, Konturek SJ, Pajdo R, Drozdowicz D, Ptak A, Pawlik M, Stachura J, Pawlik WW, Hahn EG.
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [Abstract] [Full Text] [Related]

  • 23. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
    Kato S, Ozawa K, Koike T, Sekine H, Ohara S, Minoura T, Iinuma K.
    Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
    [Abstract] [Full Text] [Related]

  • 24. [The prognostic value of gastric metaplasia in the duodenal mucosa in patients with Helicobacter pylori positive duodenal bulb ulcer].
    Marshalko OV, Konorev MR.
    Klin Med (Mosk); 2008 Apr; 86(2):43-8. PubMed ID: 18368792
    [Abstract] [Full Text] [Related]

  • 25. Serum gastrin level and pepsinogen I/II ratio as biomarker of Helicobacter pylori chronic gastritis.
    Arinton IG.
    Acta Med Indones; 2010 Jul; 42(3):142-6. PubMed ID: 20724767
    [Abstract] [Full Text] [Related]

  • 26. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A, Rugge M.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [Abstract] [Full Text] [Related]

  • 27. Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer.
    Itoh T, Seno H, Kita T, Chiba T, Wakatsuki Y.
    Scand J Gastroenterol; 2005 Jun; 40(6):641-7. PubMed ID: 16036523
    [Abstract] [Full Text] [Related]

  • 28. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M, Lapina S, Polaka I, Rudzite D, Vilkoite I, Daugule I, Belkovets A, Pimanov S, Makarenko J, Tolmanis I, Lejnieks A, Boka V, Rumba-Rozenfelde I, Vikmanis U.
    Medicina (Kaunas); 2014 Jun; 50(1):8-13. PubMed ID: 25060199
    [Abstract] [Full Text] [Related]

  • 29. [Decrease of basal levels of gastrin following H. pylori eradication].
    Gisbert JP, Boixeda D, Vila T, de Rafael L, Alvarez Baleriola I, Moreira V, Martín de Argila C, Arocena C, García Plaza A.
    Rev Esp Enferm Dig; 1995 Feb; 87(2):99-107. PubMed ID: 7748715
    [Abstract] [Full Text] [Related]

  • 30. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP, Boixeda D, Al-Mostafa A, Vila T, de Rafael L, Alvarez Baleriola I, de Argila CM, Abraira V.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [Abstract] [Full Text] [Related]

  • 31. [The possibility of Helicobacter pylori being present in the resting state in the gastric mucosa of peptic acid patients after treatment].
    Loginov AS, Reshetniak VI, Mukamolova GV, Fedukova NG, Il'chenko AA, Dudik TV, Kaprel'iants AS.
    Ter Arkh; 1999 Feb; 71(2):13-6. PubMed ID: 10222545
    [Abstract] [Full Text] [Related]

  • 32. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T, Ashida K, Yamashita H, Kiyota N, Tsukamoto R, Takahashi H, Ito D, Nagamatsu R.
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [Abstract] [Full Text] [Related]

  • 33. Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication.
    Queiroz DM, Mendes EN, Rocha GA, Moura SB, Resende LM, Cunha-Melo JR, Coelho LG, Passos MC, Oliveira CA, Lima Júnior GF.
    Am J Gastroenterol; 1993 Aug; 88(8):1228-32. PubMed ID: 8338090
    [Abstract] [Full Text] [Related]

  • 34. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE, Seppälä K, Färkkilä MA, Veijola L, Sipponen P.
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [Abstract] [Full Text] [Related]

  • 35. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M, Peczek Ł, Rudnicki C, Nawrot B, Stec-Michalska K.
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [Abstract] [Full Text] [Related]

  • 36. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
    Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K.
    J Gastroenterol Hepatol; 2007 Apr; 22(4):571-6. PubMed ID: 17376053
    [Abstract] [Full Text] [Related]

  • 37. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
    Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Defarges V, Alvarez Calatayud G, Moreno L, Martín de Argila C.
    Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
    [Abstract] [Full Text] [Related]

  • 38. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY.
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [Abstract] [Full Text] [Related]

  • 39. Serum pepsinogen C: a useful marker of Helicobacter pylori eradication?
    Plebani M, Basso D, Scrigner M, Toma A, Di Mario F, Dal Bò N, Samloff IM.
    J Clin Lab Anal; 1996 Sep; 10(1):1-5. PubMed ID: 8926560
    [Abstract] [Full Text] [Related]

  • 40. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.